| Date Filed | Type | Description |
| 05/12/2023 |
4
| McCracken Joseph S (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 3,345 options to buy
@ $3.42, valued at
$11.4k
|
|
| 12/15/2022 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Savara Inc|
Txns:
| Granted 40,000 options to buy
@ $1.51, valued at
$60.4k
|
|
| 11/18/2022 |
4
| McCracken Joseph S (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Bought 4,000 shares
@ $5.03, valued at
$20.1k
|
|
| 08/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Savara Inc|
Txns:
| Granted 40,000 options to buy
@ $1.23, valued at
$49.2k
|
|
| 04/07/2020 |
4
| McCracken Joseph S (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 709 shares
@ $0
Granted 5,684 options to buy
@ $7.78, valued at
$44.2k
|
|
| 03/30/2020 |
3
| McCracken Joseph S (Director) has filed a Form 3 on LUMOS PHARMA, INC. |
| 01/22/2020 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Granted 48,500 options to buy
@ $9.84, valued at
$477.2k
|
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2019 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Savara Inc|
Txns:
| Exercised 21,682 options to buy
@ $0.82, valued at
$17.8k
Exercised 2,930 options to buy
@ $0.82, valued at
$2.4k
Exercised 5,860 options to buy
@ $1.46, valued at
$8.6k
Exercised 9,034 options to buy
@ $1.76, valued at
$15.9k
|
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2018 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Savara Inc|
Txns:
| Granted 12,000 options to buy
@ $7.33, valued at
$88k
|
|
| 06/26/2018 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Granted 10,000 options to buy
@ $11, valued at
$110k
|
|
| 04/24/2018 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Granted 41,890 options to buy
@ $9.65, valued at
$404.2k
|
|
| 04/24/2018 |
3
| McCracken Joseph S (Director) has filed a Form 3 on Kindred Biosciences, Inc. |
| 12/19/2017 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Savara Inc|
Txns:
| Granted 3,750 options to buy
@ $15.21, valued at
$57k
|
|
| 08/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/05/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/04/2017 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Nexvet Biopharma plc|
Txns:
| Exercised 500 options to buy
@ $0.125, valued at
$62.5 |
|
| 01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/07/2016 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Nexvet Biopharma plc|
Txns:
| Exercised 3,600 options to buy
@ $0.125, valued at
$450 |
|
| 07/01/2016 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Nexvet Biopharma plc|
Txns:
| Exercised 500 options to buy
@ $0.125, valued at
$62.5
Exercised 3,600 options to buy
@ $0.125, valued at
$450 |
|
| 04/04/2016 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Nexvet Biopharma plc|
Txns:
| Exercised 500 options to buy
@ $0.125, valued at
$62.5 |
|